ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: Among the 51 pediatric CML-CP patients with evaluable BCR::ABL1 transcript levels at diagnosis and 3 months, a log-reduction threshold of 0.45 was applied to stratify early molecular responses.